Our proprietary process begins with meticulous screening of the donor mother and father as well as family members for several generations. In addition to routine industry screens for bloodborne pathogens, we also screen for heritable and non-heritable conditions, environmental contaminants from medications, alcohol, drugs, tobacco, and electronic vaping. Only healthy families who meet or exceed these criteria are considered. Postnatal tissue donations are promptly collected from local hospitals by FIOR Bioscience specialists following a healthy cesarean birth. After processing, allografts are tested again to ensure they are free of contaminants or infection, and contain healthy, viable cells prior to cryopreservation.
Our lots are quarantined for 14 days and thoroughly tested for bacterial, communicable and other disease contamination by a CLIA-certified lab. In addition, plate testing is conducted in multiple phases of the process to ensure zero contamination.
Diseases that are tested for donation eligibility:
With collection of a healthy postnatal donation, complete and proper testing procedures, an FDA minimally manipulated process, and a unique cryopreservation method, you can rest assured FIOR Bioscience provides a safe and reliable product with a proven 100% Chain of Custody.